Skip to content
Teethgrinder – Lifestyle
Author:
InspireMD Inc.
InspireMD Announces Pricing of $37.5 Million Public Offering
November 13, 2026
InspireMD Announces Proposed Public Offering
November 12, 2026
InspireMD Reports Third Quarter 2026 Financial Results
November 12, 2026
InspireMD Announces FDA Approval of the CGuard® Prime TransCarotid Stent System for Transcarotid Artery Revascularization (TCAR) Procedures
November 12, 2026
InspireMD Announces Updated Timing for Third Quarter 2026 Financial Results
November 11, 2026
InspireMD to Announce Third Quarter 2026 Financial Results
October 29, 2026
InspireMD Announces Amendments to Certain Series J and Series K Warrants, Providing Potential Gross Proceeds of Up to $11 Million
September 21, 2026
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 4, 2026
InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference
September 3, 2026
InspireMD Reports Second Quarter 2026 Financial Results
August 17, 2026
1
2
Next Page
→